bibliographicCitation |
Hara T, Furukawa J, Okamura Y, Bando Y, Terakawa T, Harada K, Takahashi S, Nakano Y, Fujisawa M. The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion. Int J Urol. 2023 Sep;30(9):779–86. doi: 10.1111/iju.15231. PMID: 37317886. |